“…9 -THC, 9 -tetrahydrocannabinol; aCSF, artificial cerebral spinal fluid; AD, Alzheimer's disease; CB1, cannabinoid receptor 1; CB2, cannabinoid receptor 2; CBr, cannabinoid receptors; DG, dentate gyrus; EC, entorhinal cortex; LPS, lipopolysaccharide; NMDA, N-methyld-aspartate; PBS, phosphate buffer saline; TBS, Tris buffer saline; WIN-55212-2, (R)-(+)- [2,3-dihydro-5-methyl-3-(4-morpholinylmethyl) and treatment with NSAIDs does not reduce microglia activation in old rats, in contrast to their effectiveness in young rats (Hauss-Wegrzyniak et al, 1999), thus raising the possibility of microglial senescence (Perry et al, 1993;Streit, 2006).…”